A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis. / Nordholm, Dorte; Jensen, Marie Aarrebo; Kristiansen, Jesper; Glenthøj, Louise Birkedal; Kristensen, Tina Dam; Wenneberg, Christina; Hjorthøj, Carsten; Garde, Anne Helene; Nordentoft, Merete.

In: Schizophrenia Research, Vol. 254, 2023, p. 218-226.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nordholm, D, Jensen, MA, Kristiansen, J, Glenthøj, LB, Kristensen, TD, Wenneberg, C, Hjorthøj, C, Garde, AH & Nordentoft, M 2023, 'A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis', Schizophrenia Research, vol. 254, pp. 218-226. https://doi.org/10.1016/j.schres.2023.03.012

APA

Nordholm, D., Jensen, M. A., Kristiansen, J., Glenthøj, L. B., Kristensen, T. D., Wenneberg, C., Hjorthøj, C., Garde, A. H., & Nordentoft, M. (2023). A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis. Schizophrenia Research, 254, 218-226. https://doi.org/10.1016/j.schres.2023.03.012

Vancouver

Nordholm D, Jensen MA, Kristiansen J, Glenthøj LB, Kristensen TD, Wenneberg C et al. A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis. Schizophrenia Research. 2023;254:218-226. https://doi.org/10.1016/j.schres.2023.03.012

Author

Nordholm, Dorte ; Jensen, Marie Aarrebo ; Kristiansen, Jesper ; Glenthøj, Louise Birkedal ; Kristensen, Tina Dam ; Wenneberg, Christina ; Hjorthøj, Carsten ; Garde, Anne Helene ; Nordentoft, Merete. / A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis. In: Schizophrenia Research. 2023 ; Vol. 254. pp. 218-226.

Bibtex

@article{020de2a36b8d4068bc52a0c3d9e0b676,
title = "A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis",
abstract = "Introduction: Individuals at ultra high-risk (UHR) of psychosis exhibit significantly higher stress levels than healthy controls (HC). This study investigates how physiological stress measures differ between HC and UHR individuals and how physiological stress is associated with attenuated psychotic symptoms and changes over time in UHR individuals. Additionally, it examines how the use of medication affects physiological levels of stress. Method: The study included 72 UHR individuals and 36 HC. UHR were included according to the comprehensive assessment of at-risk mental state (CAARMS); a total-CAARMS score measured the attenuated psychotic symptoms and was calculated from the four psychosis subscales. HC and UHR were examined at baseline, and 47 UHR individuals were followed up after six months. Physiological stress measures were salivary cortisol, alpha-amylase (SAA) and heart-rate variability (HRV). Saliva was collected at four-time points during the day. Results: There was no significant difference regarding cortisol (awakening response) or SAA measures between HC and UHR individuals. The use of antipsychotics and antidepressants was associated with low HRV in UHR individuals. In an exploratory analysis of 19 UHR individuals, we found an association between the change in total-CAARMS (six months total-CAARMS minus baseline total CAARMS) and the change in HRV during sleep (six months HRV minus baseline HRV). Conclusion: Our findings indicate that the use of antipsychotics and antidepressants could be associated with lower HRV in UHR individuals. There might be potential to investigate how HRV develops during the course of illness in UHR individuals.",
keywords = "Alpha-amylase, Clinical high-risk, Cortisol, Heart-rate variability, HRV, Stress, Ultra high-risk",
author = "Dorte Nordholm and Jensen, {Marie Aarrebo} and Jesper Kristiansen and Glenth{\o}j, {Louise Birkedal} and Kristensen, {Tina Dam} and Christina Wenneberg and Carsten Hjorth{\o}j and Garde, {Anne Helene} and Merete Nordentoft",
note = "Publisher Copyright: {\textcopyright} 2023",
year = "2023",
doi = "10.1016/j.schres.2023.03.012",
language = "English",
volume = "254",
pages = "218--226",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis

AU - Nordholm, Dorte

AU - Jensen, Marie Aarrebo

AU - Kristiansen, Jesper

AU - Glenthøj, Louise Birkedal

AU - Kristensen, Tina Dam

AU - Wenneberg, Christina

AU - Hjorthøj, Carsten

AU - Garde, Anne Helene

AU - Nordentoft, Merete

N1 - Publisher Copyright: © 2023

PY - 2023

Y1 - 2023

N2 - Introduction: Individuals at ultra high-risk (UHR) of psychosis exhibit significantly higher stress levels than healthy controls (HC). This study investigates how physiological stress measures differ between HC and UHR individuals and how physiological stress is associated with attenuated psychotic symptoms and changes over time in UHR individuals. Additionally, it examines how the use of medication affects physiological levels of stress. Method: The study included 72 UHR individuals and 36 HC. UHR were included according to the comprehensive assessment of at-risk mental state (CAARMS); a total-CAARMS score measured the attenuated psychotic symptoms and was calculated from the four psychosis subscales. HC and UHR were examined at baseline, and 47 UHR individuals were followed up after six months. Physiological stress measures were salivary cortisol, alpha-amylase (SAA) and heart-rate variability (HRV). Saliva was collected at four-time points during the day. Results: There was no significant difference regarding cortisol (awakening response) or SAA measures between HC and UHR individuals. The use of antipsychotics and antidepressants was associated with low HRV in UHR individuals. In an exploratory analysis of 19 UHR individuals, we found an association between the change in total-CAARMS (six months total-CAARMS minus baseline total CAARMS) and the change in HRV during sleep (six months HRV minus baseline HRV). Conclusion: Our findings indicate that the use of antipsychotics and antidepressants could be associated with lower HRV in UHR individuals. There might be potential to investigate how HRV develops during the course of illness in UHR individuals.

AB - Introduction: Individuals at ultra high-risk (UHR) of psychosis exhibit significantly higher stress levels than healthy controls (HC). This study investigates how physiological stress measures differ between HC and UHR individuals and how physiological stress is associated with attenuated psychotic symptoms and changes over time in UHR individuals. Additionally, it examines how the use of medication affects physiological levels of stress. Method: The study included 72 UHR individuals and 36 HC. UHR were included according to the comprehensive assessment of at-risk mental state (CAARMS); a total-CAARMS score measured the attenuated psychotic symptoms and was calculated from the four psychosis subscales. HC and UHR were examined at baseline, and 47 UHR individuals were followed up after six months. Physiological stress measures were salivary cortisol, alpha-amylase (SAA) and heart-rate variability (HRV). Saliva was collected at four-time points during the day. Results: There was no significant difference regarding cortisol (awakening response) or SAA measures between HC and UHR individuals. The use of antipsychotics and antidepressants was associated with low HRV in UHR individuals. In an exploratory analysis of 19 UHR individuals, we found an association between the change in total-CAARMS (six months total-CAARMS minus baseline total CAARMS) and the change in HRV during sleep (six months HRV minus baseline HRV). Conclusion: Our findings indicate that the use of antipsychotics and antidepressants could be associated with lower HRV in UHR individuals. There might be potential to investigate how HRV develops during the course of illness in UHR individuals.

KW - Alpha-amylase

KW - Clinical high-risk

KW - Cortisol

KW - Heart-rate variability

KW - HRV

KW - Stress

KW - Ultra high-risk

U2 - 10.1016/j.schres.2023.03.012

DO - 10.1016/j.schres.2023.03.012

M3 - Journal article

C2 - 36996675

AN - SCOPUS:85150820885

VL - 254

SP - 218

EP - 226

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

ER -

ID: 345061791